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The Editorial on the Research Topic
Engineering synthetic metabolons: from metabolic modelling to rational design of biosynthetic 
devices
Synthetic Biology is an emerging discipline that enjoys rapidly increasing popularity. However, there 
is no widely accepted definition for the term Synthetic Biology, because the field of Synthetic Biology 
is multifaceted and rapidly moving. As viewed from its underlying principle, Synthetic Biology 
can be defined as the “application of engineering principles to biological systems.” It reaches from 
pathway engineering in living systems, i.e., the introduction of functional biochemical pathways 
into existing organisms (see featured research topic review by Pröschel et al. and references cited 
therein), and the design of vesicle-based multicompartmented biochemical reactors and protocells 
(see featured research topic review by Schmitt et al. and references cited therein) to the creation 
of entirely synthetic cells with reproductive potential that is encoded by synthetic genes [with the 
work of Gibson et al. (2008, 2010) that attracted the greatest publicity in the recent years]. Likewise, 
the definition provided at http://syntheticbiology.org covers these two extremes in that Synthetic 
Biology is defined as “(A) the design and construction of new biological parts, devices, and systems 
and (B) the re-design of existing, natural biological systems for useful purposes.” This also means that 
Synthetic Biology is not limited to living systems but also comprises the combination and re-design 
of biological parts into artificial bioreactors. In this respect, Synthetic Biology is highly interdiscipli-
nary, bringing together molecular biology with biophysics, material sciences, bioengineering, and 
computational approaches.
Besides the invaluable role in helping biochemists understand the metabolic complexity of living 
systems and the extent to which observations from existing metabolic engineering strategies match 
predictions from large-scale modeling (see, e.g., the featured research topic article by Basler et al.), 
models are crucial for the rational design of synthetic systems (see, e.g., the featured research topic 
article by Elbinger et al.). Metabolic modeling has the capacity to guide the biochemical layout of 
engineered pathways in vivo and the design of artificial bioreactors in vitro. For instance, compu-
tational modeling can play an important role for the selection of individual enzyme isoforms for 
engineered metabolic pathways. Vice versa, in vitro studies in artificial bioreactors has advanced our 
understanding of biochemically complex processes, such as starch biosynthesis, as summarized in the 
featured research topic review by O’Neill and Field. On the other hand, molecular dynamics simula-
tions help to understand complex biochemical and biophysical processes such as enzymatic catalysis, 
molecular interactions of biomolecules (see featured research topic reviews by Horn and Sticht 
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and Groß et al.), or membrane transport (see featured research 
topic articles by Róg et al., Bertelshofer et al. and Sun et al.). The 
knowledge gained by these simulations can be exploited for the 
structural and molecular design of synthetic systems, i.e., for the 
choice of artificial protein or nucleic acid scaffolds for the spatial 
modular organization of artificial systems (see featured research 
topic review by Pröschel et al. and references cited therein).
This research topic focuses on the importance of computa-
tional modeling for the rational design of synthetic systems on all 
these levels. Consequently, a wide variety of approaches is being 
covered in this issue, from pathway engineering in eukaryotic 
cells to molecular dynamics simulations of transport processes. 
The modeling approaches range from partial differential equa-
tions, allowing predictions of spatiotemporal concentration of 
metabolites in a biochemical microreactor (see featured research 
topic original research article by Elbinger et al.), to steady-state 
equations, testing the effect of metabolic engineering strategy in 
large-scale metabolic networks (see, e.g., the featured research 
topic article by Basler et al.). A new metabolic engineering strat-
egy for the glucosinolate pathway that increases dihomomethio-
nine levels without increasing the levels of leucine-derived side 
products was experimentally validated in Nicotiana benthamiana 
(see featured research topic original research article by Crocoll 
et  al. and references to previous attempts therein). Sharing of 
modeling results and ensuring reproducibility of model-data 
integration requires setting and following a set of standards, 
which are currently established in the context of metabolomics 
research (see featured research topic review by Hill et al.).
The majority of the articles covered in this research topic 
article is contributed by members of the interdisciplinary 
project SynBio  that is funded by the emerging fields initiative 
of the Friedrich-Alexander-Universität Erlangen-Nürnberg 
(Germany).
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